Literature DB >> 22117963

Interleukin 2 receptor α gene polymorphism and risk of multiple sclerosis: a meta-analysis.

L-M Wang1, D-M Zhang, Y-M Xu, S-L Sun.   

Abstract

This meta-analysis studied the association between interleukin 2 receptor α (IL2RA) gene polymorphisms rs2104286 and rs12722489 and susceptibility to multiple sclerosis (MS). Case-control genetic association studies published before January 2011 were retrieved from the PubMed and EMBASE databases and the Cochrane Library. Eight studies comprising 13 569 patients and 23 435 controls met the selection criteria for meta-analysis of the IL2RA rs2104286 polymorphism. Using a fixed-effects model, the T allele and the TT and TT + TC genotypes of the IL2RA rs2104286 polymorphism were found to be associated with MS. Five studies comprising 5643 patients and 6415 controls met the selection criteria for meta-analysis of the IL2RA rs12722489 polymorphism. Using a fixed-effects model, the C allele and the CC genotype of the IL2RA rs12722489 polymorphism were found to be associated with MS but the CC + CT genotype was not. It was concluded that both of the IL2RA gene polymorphisms, rs2104286 and rs12722489, were associated with increased susceptibility to MS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22117963     DOI: 10.1177/147323001103900505

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  7 in total

Review 1.  Stage-specific immune dysregulation in multiple sclerosis.

Authors:  Benjamin M Segal
Journal:  J Interferon Cytokine Res       Date:  2014-08       Impact factor: 2.607

2.  Whole exome sequencing identified a novel splice donor site variant in interleukin 2 receptor alpha chain.

Authors:  Nadia Waheed; Maryam Naseer; Nighat Haider; Sufyan Suleman; Asmat Ullah
Journal:  Immunogenetics       Date:  2022-10-04       Impact factor: 3.330

3.  Genetic variants in IL2RA and IL7R affect multiple sclerosis disease risk and progression.

Authors:  Anthony L Traboulsee; Cecily Q Bernales; Jay P Ross; Joshua D Lee; A Dessa Sadovnick; Carles Vilariño-Güell
Journal:  Neurogenetics       Date:  2014-04-26       Impact factor: 2.660

Review 4.  Emerging immunopharmacological targets in multiple sclerosis.

Authors:  Mojtaba Farjam; Guang-Xian Zhang; Bogoljub Ciric; Abdolmohamad Rostami
Journal:  J Neurol Sci       Date:  2015-09-14       Impact factor: 3.181

5.  CD6 gene polymorphism rs17824933 is associated with multiple sclerosis in Indian population.

Authors:  Mary Anitha D'Cunha; Lekha Pandit; Chaithra Malli
Journal:  Ann Indian Acad Neurol       Date:  2016 Oct-Dec       Impact factor: 1.383

6.  The single nucleotide variant rs12722489 determines differential estrogen receptor binding and enhancer properties of an IL2RA intronic region.

Authors:  Marina A Afanasyeva; Lidia V Putlyaeva; Denis E Demin; Ivan V Kulakovskiy; Ilya E Vorontsov; Marina V Fridman; Vsevolod J Makeev; Dmitry V Kuprash; Anton M Schwartz
Journal:  PLoS One       Date:  2017-02-24       Impact factor: 3.240

7.  Is a hypothetical melanoma-like neuromelanin the underlying factor essential for the aetiopathogenesis and clinical manifestations of multiple sclerosis?

Authors:  Bernd Krone; John M Grange
Journal:  BMC Neurol       Date:  2013-07-18       Impact factor: 2.474

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.